Characteristics and predictors of women who obtain rescreening for sexually transmitted infections using the www.iwantthekit.org screening programme

International Journal of STD and AIDS

Volumn 24, Issue 9, 2013, Pages 736-744

  Gaydos, Charlotte A ^a   Barnes, Mathilda ^a   Jett Goheen, Mary ^a   Quinn, Nicole ^a   Whittle, Pamela ^b   Hogan, Terry ^a   Hsieh, Yu Hsiang ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b BALTIMORE CITY HEALTH DEPARTMENT   (United States)

Author keywords

Chlamydia (Chlamydia trachomatis); epidemiology; gonorrhea; home collection; Neisseria gonorrhoeae; postal kit testing; screening; sexual behaviour; sexually transmitted infection; Trichomonas vaginalis; trichomoniasis

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CONDOM; CONTROLLED STUDY; FEMALE; GONORRHEA; HIGH RISK BEHAVIOR; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; RESCREENING; SEXUALLY TRANSMITTED DISEASE; TRICHOMONIASIS; VAGINA SMEAR; VAGINA SMEAR KIT; WEB BROWSER;

CHLAMYDIA (CHLAMYDIA TRACHOMATIS); EPIDEMIOLOGY; GONORRHEA; HOME COLLECTION; NEISSERIA GONORRHOEAE; POSTAL KIT TESTING; SCREENING; SEXUAL BEHAVIOUR; SEXUALLY TRANSMITTED INFECTION; TRICHOMONAS VAGINALIS; TRICHOMONIASIS;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; INTERNET; MASS SCREENING; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UNITED STATES; YOUNG ADULT;

EID: 84887362731     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462413483252     Document Type: Article

References (37)

1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2010. Atlanta, GA: U.S. Department of Health and Human Services, 2010. CDC 2011, pp.1-155.
2. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2007;147:128-134.
3. National committee for Quality Assurance. The State of Health Care Quality 2010: HEDIS Measures of Care, Washington, DC, http://www ncqa org/portals/0/state%20of%20health%20care/2010/SOHC%202010%20-%20Full2 pdf 2010; pp.43-44 (accessed 10 December 2010).
4. Maciosek MV,Coffield AB,Edwards NM, et al.Priorities among effective clinical preventive services: results of a systematic review and analysis.Am J Prev Med. 2006;31:52-61.
5. Jiang N,Kolbe LJ,Seo D-C, et al.Health of adolescents and young adults: trends in achieving the 21 critical National Health Objectives by 2010.J Adol Health. 2011;49:124-132.
6. Sexually transmitted disease treatment guidelines 2010.MMWR. 2010;59:1-110.
7. Van Der Pol B,Williams JA,Orr DP, et al.Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.J Infect Dis. 2005;192:2039-2044.
8. Weinstock H,Berman S,Cates W.Sexually transmitted disease among American youth: Incidence and prevalence estimates.Perspect Sex Repro Health. 2004;36:6-10.
9. Cotch MF,Pastorek JG,Nugent RP, et al.Trichomonas vaginalis associated with low birth weight and preterm delivery.Sex Transmit Dis. 1997;24:353-360.
10. Schwebke JR,Burgess D.Trichomoniasis.Clin Microbiol Rev. 2004;17:794-803.
11. McClelland RS,Sangare L,Hassan WM, et al.Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.J Infect Dis. 2007;195:698-702.
12. Van Der Pol B,Kwok C,Pierre-Louis B, et al.Trichomonas vaginalis Infection and Human Immunodeficiency Virus Acquisition in African Women.J Infect Dis. 2008;197:548-554.
13. Kissinger P,Amadee A,Clark RA, et al.Trichomonas Vaginalis treatment reduces vaginal HIV-1 shedding.Sex Transmit Dis. 2009;36:11-16.
14. Moodley P,Wilkinson D,Connolly C, et al.Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.Clin Infect Dis. 2002;34:519-522.
15. Kissinger P,Secor WE,Leichliter JS, et al.Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.Clin Inf Dis. 2008;46:994-999.
16. Hughes J,Baeten J,Lingappa J, et al.Determinants of per-coital act HIV-1 infectivity among African HIV-1-serodiscordant couples.J Infect Dis. 2012;205:358-365.
17. Sutton M,Sternberg M,Koumans EH, et al.The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.Clin Inf Dis. 2007;45:1319-1326.
18. Allsworth JE,Ratner JA,Peipert JF.Trichomonas and other sexually transmitted infections: Results from the 2001-2004 National Health and Nutrition Examination Surveys.Sex Transmit Dis. 2009;36:738-744.
19. Miller WC,Swygard H,Hobbs MM, et al.The prevalence of trichomoniasis in young adults in the United States.Sex Tansmit Dis. 2005;32:593-598.
20. Gaydos CA,Hsieh Y-H,Barnes M, et al.Trichomonas vaginalis infection in women who submit self-collected vaginal samples after Internet recruitment.Sex Transm Dis. 2011;38:828-832.
21. Owusu-Edusei K,Tejani MN,Gift TL, et al.Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005.Sex Transmit Dis. 2009;36:395-399.
22. Van Der Pol B.Trichomonas vaginalis infection: The most prevalent nonviral sexually transmitted infection receives the least public health attention.Clin Infect Dis. 2007;44:23-25.
23. McClelland RS.Trichomonas vaginalis infection: can we afford to do nothing?.J Infect Dis. 2008;197:487-489.
24. Hobbs MM,Van Der Pol B,Totten P, et al.From the NIH: Proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections.Sex Transmit Dis. 2008;35:8-13.
25. Gaydos CA,Barnes M,Aumakham B, et al.Can E-technology through the Internet be used as a new tool to address the CT epidemic by home samplng and vaginal swabs?.Sex Transmit Dis. 2009;36:577-580.
26. Hillis SD,Joesoef R,Marchbanks PA, et al.Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility.Am J Obstet Gynecol. 1993;168:1503-1509.
27. Hillis SD,Nakashima A,Marchbanks PA, et al.Risk factors for recurrent Chlamydia trachomatis infection in women.Am J Obstet Gynecol. 1994;170:801-806.
28. Chow JM,Yonekura L,Richwals GA, et al.The association between Chlamydia trachomatis and ectopic pregnancy, a matched-pair, case-control study.JAMA. 1990;263:3164-3167.
29. Scholes D,Satterwhite C,Yu O, et al.Long-term trends in Chlamydia trachomatis infections and related outcomes in a US managed care population.Sex Transmit Dis. 2012;39:81-88.
30. Haggerty C,Gottlieb S,Taylor B, et al.Risk of sequelae after Chlamydia trachomatis genital infection in women.J Infect Dis. 2010;201:S134-S155.
31. Hosenfield C,Workowski K,Berman S, et al.Repeat infection with Chlamydia trachomatis and gonorrhea among females: a systematic review of the literature.Sex Transmit Dis. 2009;36:478-489.
32. Gaydos CA,Barnes MR,Aumakham B, et al.Chlamydia trachomatis age-specific prevalence in women who used an Internet-based Self-screening program compared to women who were screened in family planning clinics.Sex Transmit Dis. 2011;38:74-78.
33. Cohall A and Resnick M. Advances in health promotion for adolescents and young adults (adolescent medicine: state of the art reviews). Elk Grove Village, IL: American Academy of Pediatrics 2011.
34. Grasek AA,Secura GM,Allsworth JE, et al.Home-screening compared with clinic-based screening for sexually transmitted infections.Obstet Gynecol. 2010;115:745-752.
35. Guy R,Hocking J,Low N, et al.Interventions to increase rescreening for repeat chlamydial infection.Sex Transmit Dis. 2012;39:136-146.
36. Cook RL,Ostergaard L,Hillier SL, et al.Home screening for sexually transmitted diseases in high risk young women: randomized controlled trial.Sex Transm Inf. 2007;83:285-291.
37. Xu F,Stoner B,Taylor SN, et al.Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials.Obstet Gyneco. 2011;118:231-239.